IL-18 Enhances IL-4 Production by Ligand-Activated NKT Lymphocytes: A Pro-Th2 Effect of IL-18 Exerted Through NKT Cells
- 15 January 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 166 (2) , 945-951
- https://doi.org/10.4049/jimmunol.166.2.945
Abstract
NKT cells are a remarkably versatile population whose functional capacities are determined by cytokines present in their microenvironment. In this study, we provide evidence for a new immunoregulatory effect of the proinflammatory cytokine IL-18 on NKT cells. We found that IL-18, mainly known for its involvement in NK cell activation and in Th 1 immune responses, substantially enhanced IL-4 production as well as the percentage of IL-4+ cells among NKT lymphocytes activated by their specific ligand α-galactosylceramide (α-GalCer). The effect of IL-18 on IL-4 production by activated NKT cells took place both in vivo and in vitro and was not affected by IL-12 which increased IFN-γ secretion in the same conditions. We show that NKT cells are the main targets for IL-18-induced IL-4 production since it occurred neither in NKT-deficient mice nor after stimulation of Th2 lymphocytes. Finally, we provide evidence that the IL-4 promptly generated by NKT cells in response to IL-18 plus α-galactosylceramide in vivo can effectively contribute to the adaptive Th2 immune response by up-regulating the early activation marker CD69 on B cells. Our data support the notion that, in contrast to the exclusive IFN-γ inducer IL-12, IL-18 acts in a more subtle manner as a costimulatory factor in both pro-Th1 and pro-Th2 responses depending on the nature of the stimulation and the target cells.Keywords
This publication has 45 references indexed in Scilit:
- Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesisEuropean Journal of Immunology, 1999
- Overexpression of Natural Killer T Cells Protects Vα14-Jα281 Transgenic Nonobese Diabetic Mice against DiabetesThe Journal of Experimental Medicine, 1998
- IGIF Does Not Drive Th1 Development but Synergizes with IL-12 for Interferon-γ Production and Activates IRAK and NFκBImmunity, 1997
- MOUSE CD1-SPECIFIC NK1 T CELLS: Development, Specificity, and FunctionAnnual Review of Immunology, 1997
- Requirement of IL-7 for IL-4-producing potential of MHC class I- selected CD4-CD8-TCR alpha beta+ thymocytesInternational Immunology, 1997
- Early quantitative and functional deficiency of NK1+‐like thymocytes in the NOD mouseEuropean Journal of Immunology, 1996
- IL-7 reverses NK1+ Tcell-defective IL-4 production in the non-obese diabetic mouseInternational Immunology, 1996
- Role of NK1.1 + T Cells in a T H 2 Response and in Immunoglobulin E ProductionScience, 1995
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- A Subset of CD4 + Thymocytes Selected by MHC Class I MoleculesScience, 1994